Revised SPC: Biktarvy 50 mg/200 mg/25 mg (bictegravir/emtricitabine/tenofovir alafenamide fumarate) film-coated tablets
Stevens-Johnson Syndrome has been added to SPC as a rare adverse event.
Source:
electronic Medicines compendium
Stevens-Johnson Syndrome has been added to SPC as a rare adverse event.
electronic Medicines compendium